Zymeworks Appoints New EVP and CFO; Leadership Transition
Company Announcements

Zymeworks Appoints New EVP and CFO; Leadership Transition

Zymeworks (ZYME) has provided an announcement.

Zymeworks Inc. announced the appointment of Ms. Leone Patterson as Executive Vice President, Chief Business Officer, and Chief Financial Officer, with her employment beginning on September 1, 2024. Concurrently, Mr. Kenneth Galbraith stepped down from his interim CFO role but maintains his position as Chair of the Board, CEO, and President, with no changes to his compensation or terms of employment.

Find detailed analytics on ZYME stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyZymeworks price target raised to $12 from $10 at H.C. Wainwright
TipRanks Canadian Auto-Generated NewsdeskZymeworks to Showcase New Cancer Treatments at Major Conference
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App